Since then it has been repurposed for the treatment of familial adenomatous polyposis (congenital, hereditary and neonatal diseases) based on its interaction with histone deacetylase 2 (HDAC2), as shown in Table 3. Here, HDAC2 is linked to Familial adenomatous polyposis.